Fitish Review

Our assessment

Fitish is a shop. Every lane it sells has a public product page with a figure and an add-to-cart button, and two of those lanes are ones this market is short of: a needle-free daily tirzepatide tablet, and a separately priced microdose of each injectable that the page says plainly does not titrate up. It also prints a zero next to every real price, a display inconsistency that can make the actual charge harder to identify.

Two lanes most sellers don't separate

Microdosing appears on plenty of sites as a talking point. Here it is a product with its own price and its own description: a lower, fixed dose that does not titrate up, sold beside the full-dose version of the same drug at a different figure. A few other sellers run a microdose lane — Remedy Meds and the Center for Medical Weight Loss among them — but most only talk about it.

The oral tablet is the other one. The page calls it a needle-free alternative to the weekly injection and prices it at the same figure as the full-dose injectable tirzepatide, so it is a real choice you can make on the page rather than after an intake.

Both lanes exist for semaglutide and tirzepatide, so you can compare four combinations without talking to anyone.

What the price includes, and what it covers

The FAQ on the product page answers the cost question directly: the figure includes the provider consult, the medication if approved, and shipping, with no separate consult or membership fee. That is a complete answer, and few sellers give one.

The tablet page goes further than most and states the length of the supply in weeks. That single parenthesis is the difference between a figure you can annualize and a figure you have to guess at.

The two injectable pages don't repeat it. They say a monthly supply and stop.

The zero that is not a price

Every product page renders the price twice with a zero between the two. It is a default the shopping platform emits when no compare-at value is set. It is not an offer and it is not a discount.

Skim the block and you can easily read the wrong one of the three figures. The middle number is the one to ignore.

Who is behind it

The privacy policy describes the seller as a Texas limited liability company at a Fort Worth address and gives no fuller corporate name. The trading name is the only name.

No compounding pharmacy is named — the pages say a licensed compounding pharmacy and leave it there. No prescribing clinician is named, and no list of served states appears.

The GLP-1 lanes sit inside a wider catalog that also sells peptides, a nasal spray, skin products and hormone lines, so this is a storefront with a weight-loss aisle rather than a weight-loss service.

It carries an FDA warning letter issued in June 2026 over false and misleading claims and misbranding. That is a disclosure and it does not move this seller's position here.